Menu
About Us
Our Purpose, Mission and Values
Our Story So Far
Our Leadership Team
Videos & Presentations
Lung Cancer
Key Statistics
Our LungLB® Test
Informative Videos
News
RNS Announcements
Press Inquiries
Investors
Description of the Business
Directors
Corporate Governance
Company Information
Shareholder Information
Financial Information
Advisors
Contact Us
close
Lung
Cancer
Our Purpose:
To be a driving force in the early detection of lung cancer.
Key Statistics about Lung Cancer
High Prevalence
Someone in US diagnosed every 2.5 mins
Almost 25% of all cancer deaths in US; 130,180 deaths in 2022
Poor Early Detection
Surgery can cure – but only 20% of US cases diagnosed early
>1.5m lung nodules identified p.a. in US
Lack of Screening
c. 14.2m Americans eligible for free screening (2020: 6.8m)
Only 5.8% of those eligible are screened
LungLife AI licensure/accreditation information posted here.
© 2023 LungLIfe AI, Inc.
All rights reserved. LiquidBiopsy is a trademark of LungLife AI, Inc.
About Us
Our Purpose, Mission and Values
Our Story So Far
Our Leadership Team
Videos & Presentations
Lung Cancer
Key Statistics
Our LungLB® Test
Informative Videos
News
RNS Announcements
Press Inquiries
Investors
Description of the Business
Directors
Corporate Governance
Company Information
Shareholder Information
Financial Information
Advisors
Contact Us
search
close
tint
twitter
bars
linkedin
medkit
line-chart
hourglass-2
percent
cross
chevron-down
LungLife AI licensure/accreditation information posted here.